Market Cap (In CNY)
3.39 Billion
Revenue (In CNY)
443.8 Million
Net Income (In CNY)
91.37 Million
Avg. Volume
2.59 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 9.98-30.12
- PE
- -
- EPS
- -
- Beta Value
- 0.629
- ISIN
- CNE100005X31
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Dewei Yi
- Employee Count
- -
- Website
- https://www.cabio.cn
- Ipo Date
- 2019-12-19
- Details
- Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. Its products are used in infant formula food, health food, dietary supplements, and other fields for special medical purposes, pet nutrition food, economic animal feed, personal care and cosmetics, and other fields. The company was founded in 1999 and is based in Wuhan, the People's Republic of China.
More Stocks
-
RELAXORelaxo Footwears Limited
RELAXO
-
002922
-
TRITrifast plc
TRI
-
RGS
-
ARGNFargenx SE
ARGNF
-
HLUN-AH. Lundbeck A/S
HLUN-A
-
KRIDHANINFKridhan Infra Limited
KRIDHANINF
-
SDXOFSodexo S.A.
SDXOF